Target intelligence / Profile preview

Transmembrane protein 150C (TMEM150C)

Target
TMEM150C
Molecular classification
Ion channel, Mechanosensitive ion channel, Transmembrane protein
01

Overview

Transmembrane protein 150C (TMEM150C), also known as Tentonin 3 (TTN3), is a mechanosensitive ion channel component found in the plasma membrane and within various organelles. It is primarily responsible for slowly adapting mechanically activated (SA-type MA) currents, especially in dorsal root ganglion (DRG) sensory neurons but is also expressed in muscle spindles, baroreceptors, and pancreatic β cells[1][2][4][7]. TMEM150C forms a nonselective cationic channel, notably permeable to calcium ions, and its activity is essential in mechanotransduction, a process where mechanical forces are converted to biochemical signals. TMEM150C's current can be inhibited by known mechanosensitive channel blockers, and its genetic ablation impairs related physiological functions such as proprioception and blood pressure regulation and affects insulin secretion[1][2][7]. The pathophysiological roles of TMEM150C extend to cancer, Parkinson’s disease, cardiomyopathy, sensory disorders, and rare inherited diseases, although clinical targeting or biomarkers for this protein have not yet been clearly established[1][2][8]. Some studies debate whether TMEM150C forms a channel by itself or acts as a regulator of classical mechanosensitive channels such as Piezo1, Piezo2, and TREK-1[3], but its mechanosensitive properties and contributions to cellular responses are well supported by genetic models and biophysical recordings[1][4][7].

Other names
Tentonin 3TTN3FLJ12993tentonin 3transmembrane protein 150C
02

Mechanism of action

Mechanosensitive ion channel blocker action (e.g., inhibition by gadolinium, FM1-43, GsMTx4)[1][7]

03

Biological functions

MechanotransductionRegulation of mechanically activated currentsSensory neuron mechanosensitivityGlucose-stimulated insulin releaseBaroreceptor functionMuscle spindle function
04

Disease associations

HypertensionTachycardiaBaroreflex impairmentCancerParkinson’s diseaseCardiomyopathyAuditory neuropathy spectrum disorderOsteogenesis imperfectaInfantile hypomyelination

Beyond the preview

Go deeper on Transmembrane protein 150C (TMEM150C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 150C (TMEM150C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call